Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
85.64
-4.36 (-4.84%)
At close: Dec 1, 2025, 4:00 PM EST
86.43
+0.79 (0.92%)
After-hours: Dec 1, 2025, 6:57 PM EST

Protagonist Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
209.22434.436026.5827.3628.63
Upgrade
Revenue Growth (YoY)
-35.39%624.05%125.72%-2.84%-4.44%12293.07%
Upgrade
Gross Profit
209.22434.436026.5827.3628.63
Upgrade
Selling, General & Admin
42.3743.4633.4931.7427.218.64
Upgrade
Research & Development
147.84138.13120.16126.22126.0174.51
Upgrade
Operating Expenses
190.21181.59153.65157.95153.293.14
Upgrade
Operating Income
19.01252.84-93.65-131.37-125.85-64.52
Upgrade
Interest Expense
------0.6
Upgrade
Interest & Investment Income
28.8826.3214.94.060.440.9
Upgrade
Currency Exchange Gain (Loss)
0.190.25-0.2-0.08-0.15-0.05
Upgrade
EBT Excluding Unusual Items
48.08279.41-78.96-127.39-125.55-64.26
Upgrade
Other Unusual Items
------0.59
Upgrade
Pretax Income
48.07279.41-78.96-127.39-125.55-64.85
Upgrade
Income Tax Expense
2.164.22---1.31
Upgrade
Net Income
45.91275.19-78.96-127.39-125.55-66.15
Upgrade
Net Income to Common
45.91275.19-78.96-127.39-125.55-66.15
Upgrade
Shares Outstanding (Basic)
636257494634
Upgrade
Shares Outstanding (Diluted)
646557494634
Upgrade
Shares Change (YoY)
0.97%14.65%15.74%5.87%34.67%32.84%
Upgrade
EPS (Basic)
0.734.47-1.39-2.60-2.71-1.92
Upgrade
EPS (Diluted)
0.724.23-1.39-2.60-2.71-1.92
Upgrade
Free Cash Flow
63.71182.8-70.85-108.93-108.97-72.96
Upgrade
Free Cash Flow Per Share
0.992.81-1.25-2.22-2.35-2.12
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
9.09%58.20%-156.09%-494.24%-460.01%-225.36%
Upgrade
Profit Margin
21.94%63.34%-131.59%-479.26%-458.94%-231.07%
Upgrade
Free Cash Flow Margin
30.45%42.08%-118.08%-409.81%-398.31%-254.84%
Upgrade
EBITDA
20.03253.67-92.68-130.34-125.03-63.57
Upgrade
EBITDA Margin
9.57%58.39%-154.46%---222.05%
Upgrade
D&A For EBITDA
1.020.830.981.030.810.95
Upgrade
EBIT
19.01252.84-93.65-131.37-125.85-64.52
Upgrade
EBIT Margin
9.09%58.20%-156.09%---225.36%
Upgrade
Effective Tax Rate
4.50%1.51%----
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q